Analysis and Validation of the Network Pharmacology of the Mechanism of Glycyrrhetinic Acid for the Treatment of High-Altitude Pulmonary Hypertension

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left">Protein</td><td class="align_center">Identifier</td><td class="align_center">Score</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left">PTGS1</td><td class="align_center">6Y3C</td><td class="align_center">−9.4</td></tr><tr><td class="align_left">MMP1</td><td class="align_center">1CGE</td><td class="align_center">−7.4</td></tr><tr><td class="align_left">SERPINA6</td><td class="align_center">2VDX</td><td class="align_center">−7.9</td></tr><tr><td class="align_left">NOS2</td><td class="align_center">1NSI</td><td class="align_center">−9.7</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Molecular docking between 18<i>β</i>-GA and the key target protein.</div>

Journal of Food Biochemistry

tab2

Table 2

Table 2: Analysis and Validation of the Network Pharmacology of the Mechanism of Glycyrrhetinic Acid for the Treatment of High-Altitude Pulmonary Hypertension 

Table 2 | Analysis and Validation of the Network Pharmacology of the Mechanism of Glycyrrhetinic Acid for the Treatment of High-Altitude Pulmonary Hypertension 